These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 17598272)
41. New UN agency examines patent protection for traditional knowledge. Kapp C Lancet; 2001 May; 357(9267):1510. PubMed ID: 11377618 [No Abstract] [Full Text] [Related]
42. Science and law. View from the bench: patents and material transfers. Walsh JP; Cho C; Cohen WM Science; 2005 Sep; 309(5743):2002-3. PubMed ID: 16179461 [No Abstract] [Full Text] [Related]
43. Gene patents in Australia: where do we stand? Simmons DP; Wickham ME Nat Biotechnol; 2012 Apr; 30(4):323-4. PubMed ID: 22491279 [No Abstract] [Full Text] [Related]
44. U.S. intellectual property. Patent experts hope high court will clarify what's obvious. Kintisch E Science; 2006 Nov; 314(5803):1230-1. PubMed ID: 17124297 [No Abstract] [Full Text] [Related]
45. Tissue donors use their influence in deal over gene patent terms. Smaglik P Nature; 2000 Oct; 407(6806):821. PubMed ID: 11057626 [No Abstract] [Full Text] [Related]
46. Manufacturing convictions: why defendants are entitled to the data underlying forensic DNA kits. Mellon JN Duke Law J; 2001 Dec; 51(3):1097-137. PubMed ID: 11944660 [No Abstract] [Full Text] [Related]
47. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States. Miller CP; Ullrich JW Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591 [TBL] [Abstract][Full Text] [Related]
48. Tokyo centre takes steps to boost patent output. Saegusa A Nature; 1998 Feb; 391(6668):622. PubMed ID: 9490401 [No Abstract] [Full Text] [Related]
49. Are the Brookhill-Wilk patents impediments to market growth in cybersurgery? McLean TR; Torrance AW Int J Med Robot; 2008 Mar; 4(1):3-9. PubMed ID: 18275034 [TBL] [Abstract][Full Text] [Related]
50. Patent law and pharmaceutical products. A comparative study of the legal aspects of medical-pharmaceutical inventions in patent law. Schutjens MH Pharm World Sci; 1994 Jun; 16(3):161-3. PubMed ID: 7920368 [No Abstract] [Full Text] [Related]
51. Managing severe acute respiratory syndrome (SARS) intellectual property rights: the possible role of patent pooling. Simon JH; Claassen E; Correa CE; Osterhaus AD Bull World Health Organ; 2005 Sep; 83(9):707-10. PubMed ID: 16211163 [TBL] [Abstract][Full Text] [Related]
52. The MTA-rip it up and start again? Ku K; Henderson J Nat Biotechnol; 2007 Jul; 25(7):721-4. PubMed ID: 17621290 [No Abstract] [Full Text] [Related]
53. Staving off death: a case study of the pharmaceutical industry's strategies to protect blockbuster franchises. Gorlin DI Food Drug Law J; 2008; 63(4):823-64. PubMed ID: 19601385 [No Abstract] [Full Text] [Related]
54. [Intellectual property in natural sciences]. Twardowski T Postepy Biochem; 2008; 54(1):20-3. PubMed ID: 18610578 [TBL] [Abstract][Full Text] [Related]
56. Developing world gets patent aid. Butler D Nature; 2002 Feb; 415(6872):563. PubMed ID: 11832894 [No Abstract] [Full Text] [Related]
57. Patenting pluripotence: the next battle for stem cell intellectual property. Vrtovec KT; Scott CT Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018 [TBL] [Abstract][Full Text] [Related]
58. Fresh hope for German stem-cell patent case. Abbott A Nature; 2009 Nov; 462(7271):265. PubMed ID: 19924182 [No Abstract] [Full Text] [Related]
59. Health care and access to patented technologies. Garforth K Health Law J; 2005; 13():77-97. PubMed ID: 17044323 [No Abstract] [Full Text] [Related]
60. European patent law and ethics. Plomer A Drug Discov Today; 2005 Jul; 10(14):947-8. PubMed ID: 16023047 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]